Home › Posts tagged CymaBay Therapeutics

Tag: CymaBay Therapeutics

By Posted on Posted in Uncategorised

Fundamental Valuation Report Acorda Therapeutics(ACOR:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$14.74 (USD) 28/02/2019 Weighted Valuation$21.10 (USD) Overall RatingUndervalued by 43.2% Valuation Models Analyst Consensus: $23.67 (USD) (in …

Acorda Therapeutics (ACOR:NAS) Fundamental Valuation Report Read more »

Read More

By Posted on Posted in Top 25 Stock Gainers Year to Date

Stockcalc – Free Trial Have a free look inside the StockCalc website at www.stockcalc.com I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available …

AVEO Pharmaceuticals (AVEO:NAS) and Marinus Pharmaceuticals (MRNS:NAS) Are Biggest Stock Gainers YTD on NASDAQ Read more »

Read More

By Posted on Posted in Top 25 Stock Gainers Year to Date

Stockcalc – Free Trial Have a free look inside the StockCalc website at www.stockcalc.com I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available …

AVEO Pharmaceuticals (AVEO:NAS) and Leap Therapeutics (LPTX:NAS) Are Biggest Stock Gainers YTD on NASDAQ Read more »

Read More